Low-grade adenosquamous carcinoma (LGASC) is a rare invasive tumor that occurs in breast parenchyma. It has previously only been reported in females. Herein, we describe the case of a 52-year-old male who presented with a palpable mass in his right axilla that he reported had been present for 20-years. This is the first report of a male patient with LGASC. Core needle biopsy pathology revealed a benign mass of mammary origin, but its type was initially misdiagnosed. It was only correctly identified via postoperative pathology after local excision, which indicated that the mass exhibited the typical pathological characteristics of LGASC. Immunohistochemical analysis revealed positive expression of estrogen receptor, which was inconsistent with the typical "triple-negative" immunophenotype of LGASC. After resection of the mass the patient was advised to participate in regular outpatient follow-up. In conclusion, LGASC should be considered in male patients with a mass lesion in their breast or axilla, even when core needle biopsy indicates a benign mass of breast origin. One-stage local resection is recommended for the treatment of male patients with LGASC, but it is crucial to ensure that the margins are negative and postoperative adjuvant radiotherapy is not recommended.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662442 | PMC |
| http://dx.doi.org/10.3389/fonc.2020.01714 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Hormone receptor expression in low-grade adenosquamous carcinoma of the breast progressing to high-grade metaplastic carcinoma: A case report.
Medicine (Baltimore)
July 2024
Department of Otorhinolaryngology-Head and Neck Surgery, Guangzhou Red Cross Hospital of Jinan University, Guangzhou, Guangdong, China.
Rationale: Breast low-grade adenosquamous carcinoma is an uncommon cancer that has been neglected in genetic and pathophysiological research. Consequently, medical practitioners face challenges in the effective diagnosis and treatment of this condition.
Patient Concerns: We present the case of a 57-year-old Asian female patient who presented with bilateral breast masses on physical examination.
Low-Grade Adenosquamous Carcinoma of the Breast Masquerading as a Fibroepithelial Lesion on Core Biopsy: A Challenging Case.
Pathobiology
December 2024
Department of Pathology and Laboratory Medicine, KK Women's and Children's Hospital, Singapore, Singapore.
Article Synopsis
- Diagnosing low-grade adenosquamous carcinoma (LGASC) is challenging due to its subtle appearance and similarity to benign conditions, making identification difficult.
- A 53-year-old woman initially diagnosed with a benign growth underwent a wider excision, which unexpectedly revealed LGASC with some expression of estrogen receptors.
- The case underscores the diagnostic difficulties associated with LGASC, particularly when relying on small tissue samples from biopsies.
Nonneoplastic and neoplastic sclerosing lesions of the breast.
Histopathology
September 2024
Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Article Synopsis
- Sclerosing lesions of the breast are both benign and malignant and can be challenging to diagnose, requiring awareness of key characteristics to avoid misdiagnosis.
- The review highlights nonneoplastic sclerosing lesions, providing details on their clinical presentation, morphology, diagnostic considerations, and necessary immunohistochemical tests.
- It also briefly discusses atypical or neoplastic entities related to these lesions, emphasizing the importance of accurate diagnosis for effective clinical management.
Article Synopsis
- * The study analyzed 347 male patients, predominantly white, with median ages of 70, highlighting that EA had the longest median overall survival (62.9 months) compared to GEJA (33.4 months) and GA (38.1 months).
- * Prognostic factors that impacted survival include tumor location, size, differentiation, subtype, and TNM stage, with the research further categor
Emerging and under-recognised patterns of colorectal carcinoma morphologies: a comprehensive review.
J Clin Pathol
June 2024
Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
While the overwhelming majority of colorectal carcinomas (CRC) are diagnosed as adenocarcinoma not otherwise specified, there are numerous under-recognised morphologic patterns of CRC. These patterns are recognised by the WHO, appear in reporting manuals for the American Joint Committee of Cancer, and/or are listed on synoptic reports, while many other variants have either fallen out of favour or are emerging as future bona fide patterns. Herein, we discuss 13 variants: serrated adenocarcinoma, micropapillary adenocarcinoma, medullary carcinoma, neuroendocrine carcinoma, mucinous adenocarcinoma, signet-ring cell carcinoma, adenosquamous carcinoma, adenoma-like adenocarcinoma, lymphoglandular complex-like CRC, carcinoma with sarcomatoid components, cribriform-comedo-type adenocarcinoma, undifferentiated carcinoma and low-grade tubuloglandular adenocarcinoma.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!